# HUMA (Humacyte, Inc.) - SEC EDGAR Financial Statements

> Humacyte, Inc. reported $2.40M in revenue and a net loss of $94.76M for the trailing twelve months ended September 30, 2026 (up 36.5% year over year), with a -475.1% gross margin and a -4602.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/HUMA
- Markdown: https://convexityos.com/fundamentals/HUMA.md
- SEC CIK: 0001818382
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:46 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001818382&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.40M | +36.5% YoY |
| Operating Income | TTM | -$110.3M | -4602.9% margin |
| Net Income | TTM | -$94.76M | -3955.1% net margin |
| Diluted EPS | TTM | -$0.34 | Split-adjusted |
| Free Cash Flow | TTM | -$88.58M | -3697.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $64.52M | Total debt: $66.48M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.04M | $0 | -- | -- | -- | -- |
| Cost of Revenue | $9.70M | $0 | -- | -- | -- | -- |
| **Gross Profit** | -$7.66M | $0 | -- | -- | -- | -- |
| Research & Development | $69.30M | $88.60M | $76.55M | $63.26M | $61.34M | $54.08M |
| Total Operating Expenses | -- | $114.4M | $100.0M | $86.14M | $82.47M | $66.09M |
| **Operating Income** | -$108.1M | -$114.4M | -$100.0M | -$84.58M | -$81.21M | -$64.60M |
| **EBITDA** | -$102.8M | -$109.3M | -$94.39M | -$78.43M | -$75.03M | -$58.31M |
| Interest Income | $2.59M | $4.10M | $5.47M | $2.63M | $16K | $278K |
| Interest Expense | $11.25M | $9.28M | $6.60M | $6.20M | $4.35M | $2.20M |
| Income Before Tax | -$40.83M | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$40.83M | -$148.7M | -$110.8M | -$11.96M | -$26.48M | -$66.52M |
| Basic EPS | -$0.26 | -$1.26 | -$1.07 | -$0.12 | -$0.66 | -$11.54 |
| **Diluted EPS** | -$0.26 | -$1.26 | -$1.07 | -$0.12 | -$0.66 | -$11.54 |
| Basic Shares Outstanding | 158.2M | 118.5M | 103.4M | 103.1M | 40.0M | 5.8M |
| Diluted Shares Outstanding | 158.2M | 118.5M | 103.4M | 103.1M | 40.0M | 5.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.03M | $406K | $495K | $467K | $753K | $301K | $517K | $0 |
| Cost of Revenue | $1.43M | $1.23M | $2.04M | $9.08M | $260K | $213K | $147K | $0 |
| **Gross Profit** | -$401K | -$825K | -$1.54M | -$8.62M | $493K | $88K | $370K | $0 |
| Research & Development | $14.10M | $18.14M | $19.46M | $14.61M | $17.27M | $22.01M | $15.42M | $20.66M |
| Selling, General & Admin | -- | -- | -- | -- | $7.61M | $7.81M | $8.14M | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $28.09M |
| **Operating Income** | -$23.52M | -$27.00M | -$28.93M | -$30.84M | -$24.39M | -$29.73M | -$23.18M | -$28.09M |
| **EBITDA** | -$22.24M | -$25.66M | -$27.59M | -$29.50M | -$23.09M | -$28.43M | -$21.88M | -$26.80M |
| Interest Income | $601K | $388K | $330K | $503K | $590K | $832K | $662K | $852K |
| Interest Expense | $2.37M | $2.32M | $2.27M | $3.09M | $2.61M | $2.54M | $3.00M | $2.51M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$15.54M | -$36.80M | -$17.62M | -$24.80M | -$17.51M | -$37.66M | $39.14M | -$20.94M |
| Basic EPS | -$0.06 | -$0.16 | -$0.09 | -- | -$0.11 | -$0.24 | $0.28 | -- |
| **Diluted EPS** | -$0.06 | -$0.16 | -$0.09 | -- | -$0.11 | -$0.24 | $0.28 | -- |
| Basic Shares Outstanding | 277.8M | 234.2M | 197.8M | -- | 158.3M | 155.4M | 131.5M | -- |
| Diluted Shares Outstanding | 277.8M | 234.2M | 197.8M | -- | 158.3M | 155.4M | 131.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $50.50M | $44.94M | $80.45M | $149.8M | $217.5M | $39.93M |
| Short-Term Investments | -- | -- | $0 | $2.11M | $8.00M | $0 |
| **Cash & Short-Term Investments** | $50.50M | $44.94M | $80.40M | $151.9M | $225.5M | $39.93M |
| Accounts Receivable, Net | $441K | $0 | $0 | $31K | $176K | $113K |
| Inventory | $13.59M | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $67.80M | $47.86M | $83.28M | $154.2M | $229.3M | $41.45M |
| Property, Plant & Equipment, Net | $18.54M | $23.06M | $26.79M | $30.04M | $35.03M | $40.98M |
| Long-Term Investments | -- | -- | -- | -- | -- | $100.0M |
| Other Non-Current Assets | $672K | $1.25M | $632K | $682K | -- | -- |
| **Total Non-Current Assets** | $48.57M | $90.01M | $44.95M | $50.09M | $57.19M | $65.24M |
| **Total Assets** | $116.4M | $137.9M | $128.2M | $204.3M | $286.5M | $106.7M |
| Accounts Payable | $5.40M | $4.49M | $6.49M | $1.59M | $2.09M | $2.27M |
| Other Current Liabilities | $0 | $238K | $53K | -- | -- | -- |
| **Total Current Liabilities** | $18.37M | $19.95M | $18.44M | $19.58M | $11.05M | $11.23M |
| Long-Term Debt | $35.44M | $0 | -- | -- | $30.00M | -- |
| Other Non-Current Liabilities | $1.58M | $983K | $711K | $712K | -- | -- |
| **Total Non-Current Liabilities** | $94.89M | $170.6M | $96.23M | $67.79M | $153.3M | $24.78M |
| **Total Liabilities** | $113.3M | $190.5M | $114.7M | $87.37M | $164.4M | $36.02M |
| **Total Debt (incl. Leases)** | $64.85M | $17.10M | $19.50M | $21.80M | $53.80M | $25.60M |
| Common Stock | $20K | $13K | $10K | $10K | $10K | $1.0K |
| Retained Earnings | -$726.8M | -$686.0M | -$537.3M | -$426.5M | -$414.6M | -$388.1M |
| **Total Stockholders' Equity** | $3.11M | -$52.67M | $13.55M | $116.9M | $122.2M | -$350.3M |
| Total Equity | $3.11M | -$52.67M | $13.55M | $116.9M | $122.2M | -$350.3M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $64.52M | $79.90M | $48.54M | $50.50M | $19.49M | $38.03M | $62.85M | $44.94M |
| **Cash & Short-Term Investments** | $64.52M | $79.90M | $48.54M | $50.50M | $19.49M | $38.03M | $62.85M | $44.94M |
| Accounts Receivable, Net | $811K | $330K | $434K | $441K | $1.08M | $394K | $488K | $0 |
| Inventory | $5.61M | $6.99M | $9.92M | $13.59M | $18.42M | $11.07M | $8.02M | $0 |
| **Total Current Assets** | $82.68M | $92.79M | $63.60M | $67.80M | $41.35M | $51.73M | $73.70M | $47.86M |
| Property, Plant & Equipment, Net | $14.88M | $16.17M | $17.38M | $18.54M | $19.86M | $21.19M | $22.44M | $23.06M |
| Other Non-Current Assets | $0 | $672K | $672K | $672K | $672K | $1.22M | $1.24M | $1.25M |
| **Total Non-Current Assets** | $42.89M | $45.30M | $46.96M | $48.57M | $50.16M | $87.06M | $88.85M | $90.01M |
| **Total Assets** | $125.6M | $138.1M | $110.6M | $116.4M | $91.51M | $138.8M | $162.6M | $137.9M |
| Accounts Payable | $2.82M | $4.16M | $5.08M | $5.40M | $9.57M | $6.63M | $5.57M | $4.49M |
| Other Current Liabilities | -- | -- | -- | $0 | $0 | $61K | $60K | $238K |
| **Total Current Liabilities** | $24.76M | $14.95M | $16.19M | $18.37M | $25.58M | $21.09M | $20.03M | $19.95M |
| Long-Term Debt | $36.80M | $36.32M | $35.87M | $35.44M | -- | -- | -- | $0 |
| Other Non-Current Liabilities | $1.67M | $2.09M | $1.68M | $1.58M | $520K | $984K | $951K | $983K |
| **Total Non-Current Liabilities** | $82.75M | $91.88M | $82.75M | $94.89M | $70.68M | $113.7M | $106.5M | $170.6M |
| **Total Liabilities** | $107.5M | $106.8M | $98.93M | $113.3M | $96.26M | $134.7M | $126.5M | $190.5M |
| **Total Debt (incl. Leases)** | $66.48M | $66.18M | $65.90M | $64.85M | $29.82M | $15.12M | $15.85M | $17.10M |
| Common Stock | $28K | $28K | $23K | $20K | $16K | $16K | $16K | $13K |
| Retained Earnings | -$796.8M | -$781.3M | -$744.5M | -$726.8M | -$702.0M | -$684.5M | -$646.9M | -$686.0M |
| **Total Stockholders' Equity** | $18.06M | $31.26M | $11.62M | $3.11M | -$4.75M | $4.05M | $36.04M | -$52.67M |
| Total Equity | $18.06M | $31.26M | $11.62M | $3.11M | -$4.75M | $4.05M | $36.04M | -$52.67M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$40.83M | -$148.7M | -$110.8M | -$11.96M | -$26.48M | -$66.52M |
| Depreciation & Amortization | $5.33M | $5.10M | $5.66M | $6.15M | $6.18M | $6.29M |
| Stock-Based Compensation | $9.75M | $6.14M | $6.83M | $6.18M | $10.15M | $4.69M |
| Change in Receivables | -$261K | $0 | $31K | $145K | -$63K | $488K |
| Change in Inventory | -$21.83M | $0 | -- | -- | -- | -- |
| Change in Payables | $973K | -$1.96M | $4.81M | -$509K | -$197K | -$889K |
| **Operating Cash Flow** | -$105.0M | -$98.12M | -$73.31M | -$71.13M | -$81.19M | -$55.57M |
| Capital Expenditure | -$884K | -$1.57M | -$2.28M | -$1.05M | -$220K | -$318K |
| **Free Cash Flow** | -$105.9M | -$99.69M | -$75.58M | -$72.18M | -$81.41M | -$55.89M |
| **Investing Cash Flow** | -$884K | -$1.57M | -$173K | $4.84M | -$8.22M | -$268K |
| Common Stock Issued | -- | -- | -- | -- | $242.4M | $0 |
| **Financing Cash Flow** | $61.49M | $114.2M | $4.51M | -$1.45M | $267.0M | $2.05M |
| **Net Change in Cash** | -$44.44M | $14.49M | -$68.97M | -$67.73M | $177.6M | -$53.78M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.54M | -$36.80M | -$17.62M | -$24.80M | -$17.51M | -$37.66M | $39.14M | -$20.94M |
| Depreciation & Amortization | $1.28M | $1.34M | $1.34M | $1.34M | $1.30M | $1.30M | $1.31M | $1.28M |
| Stock-Based Compensation | $2.34M | $2.61M | $3.17M | $2.47M | $2.46M | $2.33M | $2.49M | $1.69M |
| Change in Receivables | -$481K | $104K | $7.0K | $637K | -$684K | $94K | -$308K | $0 |
| Change in Inventory | $1.37M | $2.27M | $2.04M | -$3.56M | -$7.30M | -$2.95M | -$8.02M | $0 |
| Change in Payables | -$1.30M | -$912K | -$362K | -$4.16M | $2.99M | $1.49M | $653K | -$2.44M |
| **Operating Cash Flow** | -$14.97M | -$22.06M | -$25.10M | -$26.12M | -$23.90M | -$26.41M | -$28.60M | -$26.58M |
| Capital Expenditure | $0 | -$104K | -$175K | -$39K | -$49K | -$568K | -$228K | -$63K |
| **Free Cash Flow** | -$14.97M | -$22.16M | -$25.28M | -$26.16M | -$23.95M | -$26.98M | -$28.83M | -$26.64M |
| **Investing Cash Flow** | $0 | -$104K | -$175K | -$39K | -$49K | -$568K | -$228K | -$63K |
| **Financing Cash Flow** | -$406K | $53.53M | $23.32M | $57.17M | -$44.59M | $2.17M | $46.74M | $51.01M |
| **Net Change in Cash** | -$15.38M | $31.36M | -$1.96M | $31.01M | -$68.54M | -$24.82M | $17.91M | $24.37M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -376.1% | -- | -- | -- | -- | -- |
| **Operating Margin** | -5306.0% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -2003.6% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -1313.4% | -- | -817.8% | -10.2% | -21.7% | -- |
| Return on Assets (ROA) | -35.1% | -107.9% | -86.4% | -5.9% | -9.2% | -62.4% |
| Current Ratio | 3.69x | 2.40x | 4.52x | 7.88x | 20.75x | 3.69x |
| Quick Ratio | 2.95x | 2.40x | 4.36x | 7.76x | 20.42x | 3.56x |
| Debt to Equity | 20.86x | -- | 1.44x | 0.19x | 0.44x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -475.1% | -494.6% | -475.0% | -376.1% | 60.5% | 56.0% | 71.6% | -- |
| **Operating Margin** | -4602.9% | -5240.8% | -5649.2% | -5306.0% | -6708.4% | -13598.0% | -21470.8% | -- |
| **Net Profit Margin** | -3955.1% | -4560.8% | -4840.8% | -2003.6% | -2353.2% | -7171.3% | -15022.4% | -- |
| Return on Equity (ROE) | -524.6% | -309.4% | -839.6% | -1313.4% | -- | -1447.7% | -215.5% | -- |
| Return on Assets (ROA) | -75.5% | -70.1% | -88.3% | -35.1% | -40.4% | -42.3% | -47.8% | -107.9% |
| Current Ratio | 3.34x | 6.21x | 3.93x | 3.69x | 1.62x | 2.45x | 3.68x | 2.40x |
| Quick Ratio | 3.11x | 5.74x | 3.32x | 2.95x | 0.90x | 1.93x | 3.28x | 2.40x |
| Debt to Equity | 3.68x | 2.12x | 5.67x | 20.86x | -- | 3.73x | 0.44x | -- |
| **Revenue Growth (YoY)** | +36.5% | +34.9% | -4.3% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -181.3% | -1037.5% | -517.0% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -145.0% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -132.1% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
